Viewing Study NCT02148133


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2026-01-07 @ 2:26 PM
Study NCT ID: NCT02148133
Status: COMPLETED
Last Update Posted: 2019-05-03
First Post: 2014-05-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia
Sponsor: Novartis Pharmaceuticals
Organization: